01:07

ChinaBio® Partnering Forum Full Video

01:06

ChinaBio Partnering Forum highlights

00:25

Asia Bio Partnering Forum Vertical 1

00:46

Asia Bio Prtnering Forum short horizontal 3

01:25

Asia Bio Partnering Forum horizonatal full

00:25

Asia Bio Partnering Forum short horizontal 1

00:26

Asia Bio Partnering Forum short horizontal 2

00:26

Asia Bio Partnering Forum Vertical 2

00:46

Asia Bio Partnerin g Forum Vertical 3

01:25

Asia Bio Partnering Forum full Vertical

01:25

Asia Bio Partnering Forum video

00:45

Top reasons to attend Biotech Showcase

00:50

Biotech Showcase

00:52

BioPharm America™ 2023 Highlights

05:58

Interview with Derek Ansel, Worldwide Clinical Trials

01:16

ChinaBio® Partnering Forum Hybrid

07:43

Interview with Bruce Bauer, CEO of TAE Life Sciences

00:42

BIO Europe Spring Digital 2021

10:58

Interview with Dr. Mohamad Hussein, Board Member at Starton Therapeutics

05:45

Interview with Brian Roden, Director of Greenfield Chemical

06:36

Expect more with Siegfried as your preferred partner.

04:39

How the right CDMO can support your product’s path to clinic

01:10

partneringONE® ALL in ONE

25:12

ChinaBio® Partnering Forum Digital 2020: External Innovation

00:52

BIO Europe® Digital: More than the typical virtual event

00:51

Three global partnering events. One low price.

00:59

BioPharm America™ goes digital

01:44

Facilitate Innovation & Partnerships with the Global Partnering Virtual Passport

00:51

ChinaBio® Partnering Forum Digital

03:30

WellMarker Bio greatly accelerates the development of predictive biomarker-based anticancer drug

01:15

BIO-Europe Spring® | Europe’s largest springtime partnering event

10:51

Cell therapy firms need to establish commercialization plan years before launch

07:38

Neuroprotective approach might also rejuvenate malfunctioning cells in neurodegenerative patients

07:22

Seventure surpasses €200M fund target as microbiome research matures

12:23

Biopartnering drives drug R&D efficiency

10:18

AI will enable biopharma to create novel communities needed for success

12:44

Over-communication is key to biotech merger success

07:02

BiomX pursues beyond the gut microbiome opportunities

05:34

Polaryx Therapeutics aims to boost lysosome biogenesis to treat neurodegenerative disorders

03:58

Nimble Therapeutics greatly accelerates the development of peptide-based therapeutics

10:23

Rgenix cancer therapeutics company focuses on RNA to identify novel targets

09:08

PharmAbcine makes great strides in immune oncology cancer treatments with successful trials

12:43

US Policy Proposals Threaten Investor Sentiment & Biopharma Dealmaking

08:15

Mundipharma’s success rests on valuable like minded partnerships

05:00

Rousselot Biomedical's X Pure® changing the game in purified gelatins

06:39

Bioceros develops monoclonal antibodies as a division of Poland’s Polpharma Biologics Group

03:43

Fidelta focuses on drug discovery in infection and inflammation

00:41

BioPharm America™ in the biotech hub of Boston

01:34

Engage with global life science partners at BIO-Europe® 2019

01:18

Break into the inner life science circle at BioPharm America™

01:14

Discover innovation and form partnerships at BioPharm America™

10:59

BIO-Europe Spring 2019: Finally, Paion teeters on cusp of commercialization

10:17

BIO-Europe Spring 2019: Nanoform harnesses physics to enhance drug candidate viability

10:26

BIO-Europe Spring 2019: Anima brings small molecule discovery to mRNA space

09:04

BIO-Europe Spring 2019: Modra Pharmaceuticals CEO on enhancing taxanes

09:41

BIO-Europe Spring 2019: Newcomer Tubulis tackles ADC technology shortcomings

09:59

BIO-Europe Spring 2019: Themis Bioscience Harnesses Measles Vector For Immune Modulation

10:03

BIO-Europe Spring 2019: InteRNA sees microRNA potential in cancer therapy

08:34

BIO-Europe Spring 2019: Adrenomed’s Hein on sepsis and beyond

08:35

BIO-Europe Spring 2019: Mass General Looks To Learn And Lead In Research Partnering